Reader Response: Normobaric Hyperoxia Combined With Endovascular Treatment for Patients With Acute Ischemic Stroke: A Randomized Controlled Clinical Trial

Li et al. explored the role of normobaric hyperoxia (NBO) in patients with anterior circulation ischemic stroke eligible for endovascular therapy.1 They proved the feasibility, safety, and efficacy of NBO in a pilot randomized controlled train, revealing a smaller median final infarct volume (20.1 vs 37.7 mL) and infarct volume growth (8.5 vs 20.8 mL) in the treatment arm.